Saturday, 31 October 2026European Markets

SAS AB Stock Surge: Up Over 28% In 5 Sessions

Loading stream...

(VIANEWS) - SAS AB's (SASNO.OL) stock experienced an unprecedented surge of 28.211% over five trading sessions, jumping from kr0.02 to kr0.02, according to data from Oslo Bors Benchmark Index_GI at 14:46 EST on Friday - an upturn that followed recent downward trends; Oslo Bors Benchmark Index_GI saw a slight uptick of 0.66% which brought it up from 1,244.73 the previous session - yet SAS AB closed with its last closing price 96.64% lower than its 52 week high of Kr0.48!

About SAS AB

SAS AB (publ) is a Swedish airline company which offers passenger flight transportation in both its Nordic and international route networks, along with air cargo services, in-flight sales, ground handling services, technical maintenance services and travel related loyalty programs. SAS was founded in 1946 with 16 long-haul aircraft (14 long, 87 short, 31 regional) but since 2022 SAS filed Chapter 11 bankruptcy proceedings before the U.S. Bankruptcy Court for the Southern District of New York on July 5.

Yearly Analysis

As an AI language model, I can provide you with a brief analysis of SAS AB's stock using the information you provided. Based on available data, SAS AB stock is currently trading at kr0.02, below its 52-week high of kr0.48 but above its 52-week low of kr0.02. This indicates that there have been considerable price changes over the last year. Prior results should not be seen as indicative of future performance; investors should conduct additional research and analysis prior to making investment decisions.

Technical Analysis

SAS AB's stock performance has been declining as evidenced by its current price falling significantly below both its 50-day and 200-day moving averages, currently 0.03 and 0.21, respectively, which indicate selling pressure over both short and long time frames. Noteworthy is the stock's volume has been higher than average - today's reported volume was 65.05% above its 10-255600 average volume - suggesting increased interest despite its bearish trend. Regarding volatility, SAS AB's intraday variation average has been positive 1.10% over the last week, negative 2.39% for the month, and positive 4.93% over the quarter. Its highest amplitude of average volatility over this timeframe has been 21.35% over its intraday variation average over one week and 7.88% during month and quarter, with positive values for these time frames respectively. Overall, these indicators suggest that SAS AB's stock is experiencing bearish sentiment both short- and long-term; however, there may be increased investor interest for it. It is advised to closely track these trends and factors so as to make informed investment decisions.

Quarter Analysis

Revenue Growth Historically, revenue growth of the company has been strong with year-on-year quarterly revenue growth of 12.8% during the past twelve months and 42.04B being reported as its trailing twelve month revenue total.

Equity Analysis

Earnings Per Share (EPS) is a financial metric used to quantify how much profit a company generates per outstanding share. Calculated by dividing net income by the number of outstanding shares of stock held, Earnings Per Share provides a measure of how profitable businesses are relative to one another. SAS AB's trailing twelve months EPS stands at kr-0.71. This indicates that for every outstanding share of SAS AB stock held, it generated a profit of kr-0.71 over the last twelve months - meaning its net loss exceeded this figure over this timeframe. EPS is an invaluable metric for investors as it gives insight into a company's profitability and allows comparison between businesses in similar industries. But investors should keep in mind that its EPS should only be one part of an analysis when considering stock investments - other factors like revenue growth, market position and competitive landscape should also be taken into account when making decisions about them.

More news about SAS AB (SASNO.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com